Back to companies

Sangamo Therapeutics Inc: Segment Analysis

Business Description

Sangamo Therapeutics Inc (Sangamo) is a clinical stage biotechnology company that carries out the research, development and commercialization of genomic medicines built on its proprietary technologies. The company’s gene therapy technologies include ex vivo gene-edited cell therapy, in vivo genome regulation and in vivo genome editing.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

Sangamo conducts research to develop ZFP therapeutics for neurological disorders, cancer, monogenic diseases and HIV/AIDS programs. In FY2020, the company expenses were US$180.6 million in its R&D activities, which grew 23.8% YoY. The company entered into various research agreements to use its ZFP technology to develop enhanced cell lines for protein pharmaceutical production. As of February 14, 2020, the company had over 20 granted foreign patents, and two pending US patent applications.

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer